Yoshihisa Koyama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yoshihisa Koyama has a total of 146 co-authors. Here are the top co-authors by number of shared publications:
Shoichi Shimada
Graduate School of Medicine, The University of Osaka
35 shared publicationsHikaru Kobayashi
SANKEN, The University of Osaka
20 shared publicationsYuki Kobayashi
SANKEN, The University of Osaka
19 shared publications- Shoichi Shimada
Department of Neuroscience and Cell Biology, Graduate School of Medicine, The University of Osaka, Osaka, 565-0871, Japan
14 shared publications Shotaro Harada
Graduate School of Medicine, The University of Osaka
12 shared publicationsHidenori Inohara
Graduate School of Medicine, The University of Osaka
11 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21  (11) , e0361954
Evaluation of the efficacy of Si-based agent in Rheumatoid Arthritis with complicating vestibular impairment
Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent joint inflammation and progressive disability. Although current therapies have improved clinical outcomes, safer and more effective therapeutic approaches remain needed. Silicon (Si)-based agents have antioxidant and anti-inflammatory properties and have shown beneficial effects in several inflammatory disease models. Methods: We evaluated the effects of oral administration of a Si-based agent in a type II collagen-induced arthritis mouse model. Arthritis severity was assessed using an arthritis index, hindlimb oedema, and the hindlimb extension reflex test. Serum type II collagen-specific autoantibody levels were also measured. Vestibular function was evaluated using the vestibulo-ocular reflex (VOR), and inner-ear structural changes were assessed by magnetic resonance imaging and histological analysis. Results: The Si-based agent reduced arthritis-related outcomes, including the arthritis index, hindlimb oedema, and joint movement restriction, and reduced serum type II collagen-specific autoantibody levels. In contrast, no significant differences between the Si-based agent and control groups were detected in VOR-related outcomes, endolymphatic space measurements, or inner-ear histological findings. Conclusions: These findings suggest that the Si-based agent may have beneficial effects on arthritis-related manifestations. However, its effects on the vestibular function-related outcomes examined in this study were not evident. Further studies are needed to clarify the relationship between RA and vestibular dysfunction and to determine the potential therapeutic effects of Si-based agent on these complications.
- 6 November 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21  (11) , e0361954
Open AccessEvaluation of the efficacy of Si-based agent in Rheumatoid Arthritis with complicating vestibular impairment
Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent joint inflammation and progressive disability. Although current therapies have improved clinical outcomes, safer and more effective therapeutic approaches remain needed. Silicon (Si)-based agents have antioxidant and anti-inflammatory properties and have shown beneficial effects in several inflammatory disease models. Methods: We evaluated the effects of oral administration of a Si-based agent in a type II collagen-induced arthritis mouse model. Arthritis severity was assessed using an arthritis index, hindlimb oedema, and the hindlimb extension reflex test. Serum type II collagen-specific autoantibody levels were also measured. Vestibular function was evaluated using the vestibulo-ocular reflex (VOR), and inner-ear structural changes were assessed by magnetic resonance imaging and histological analysis. Results: The Si-based agent reduced arthritis-related outcomes, including the arthritis index, hindlimb oedema, and joint movement restriction, and reduced serum type II collagen-specific autoantibody levels. In contrast, no significant differences between the Si-based agent and control groups were detected in VOR-related outcomes, endolymphatic space measurements, or inner-ear histological findings. Conclusions: These findings suggest that the Si-based agent may have beneficial effects on arthritis-related manifestations. However, its effects on the vestibular function-related outcomes examined in this study were not evident. Further studies are needed to clarify the relationship between RA and vestibular dysfunction and to determine the potential therapeutic effects of Si-based agent on these complications.
- 24 October 2026
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 192, 107060
Redefining chronic pain models: What should we model?
- 24 October 2026
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 192, 107060
Redefining chronic pain models: What should we model?
- Open Access
- 23 October 2026
- Published by Springer Nature in Scientific Reports
Oxidative stress contributes to persistent pain and central sensitization in a repeated PGE2-induced hyperalgesic priming model
- 23 October 2026
- Published by Springer Nature in Scientific Reports
Open AccessOxidative stress contributes to persistent pain and central sensitization in a repeated PGE2-induced hyperalgesic priming model
- 18 September 2026
- Published by Elsevier in Next Research
- Vol. 13
Examination of the effectiveness of Si-based agent in radiotherapy using the alpha-emitting nuclide astatine
- 18 September 2026
- Published by Elsevier in Next Research
- Vol. 13
Examination of the effectiveness of Si-based agent in radiotherapy using the alpha-emitting nuclide astatine
- Open Access
- 31 August 2026
- Published by Springer Nature in Scientific Reports
Neurofunctional recovery effects of a Si-based agent in traumatic brain injury-induced chronic neuroinflammation
- 31 August 2026
- Published by Springer Nature in Scientific Reports
Open AccessNeurofunctional recovery effects of a Si-based agent in traumatic brain injury-induced chronic neuroinflammation
- 1 August 2026
- Published by American Psychological Association (APA) in Behavioral Neuroscience
- Vol. 140  (4) , 236-246
Treatment of cisplatin-induced olfactory aversion based on selection logic: A novel approach.
Aversion can arise from a combination of unconditioned stimuli that induce physical discomfort, such as pain and nausea. Chemotherapy-induced side effects, including taste and olfactory aversion, can persist even after treatment has ended, thereby reducing the quality of life. Currently, however, no effective pharmacological interventions exist for treating chemotherapy-induced conditioned aversion learning. Therefore, elucidating its underlying mechanisms is of great importance. In this study, we investigated cisplatin-induced olfactory aversion learning using the two-bottle choice test. Cisplatin was found to induce aversive responses to neutral odorants, namely isoamyl acetate and benzaldehyde. Notably, we obtained two key findings. First, an odor solution that was not aversive in the two-bottle choice test (i.e., distilled water) became aversive to mice when compared with a third novel odor solution that had not been presented in the test. Second, when pairs of three odorants were alternated over an extended period, the mice occasionally shifted their aversive responses as the pairings changed. In clinical practice, patients are exposed to a variety of odors. Thus, the new insights gained from this study on olfactory aversion may help inform the development of novel treatments for chemotherapy-related side effects. (PsycInfo Database Record (c) 2026 APA, all rights reserved).
- 1 August 2026
- Published by American Psychological Association (APA) in Behavioral Neuroscience
- Vol. 140  (4) , 236-246
Treatment of cisplatin-induced olfactory aversion based on selection logic: A novel approach.
Aversion can arise from a combination of unconditioned stimuli that induce physical discomfort, such as pain and nausea. Chemotherapy-induced side effects, including taste and olfactory aversion, can persist even after treatment has ended, thereby reducing the quality of life. Currently, however, no effective pharmacological interventions exist for treating chemotherapy-induced conditioned aversion learning. Therefore, elucidating its underlying mechanisms is of great importance. In this study, we investigated cisplatin-induced olfactory aversion learning using the two-bottle choice test. Cisplatin was found to induce aversive responses to neutral odorants, namely isoamyl acetate and benzaldehyde. Notably, we obtained two key findings. First, an odor solution that was not aversive in the two-bottle choice test (i.e., distilled water) became aversive to mice when compared with a third novel odor solution that had not been presented in the test. Second, when pairs of three odorants were alternated over an extended period, the mice occasionally shifted their aversive responses as the pairings changed. In clinical practice, patients are exposed to a variety of odors. Thus, the new insights gained from this study on olfactory aversion may help inform the development of novel treatments for chemotherapy-related side effects. (PsycInfo Database Record (c) 2026 APA, all rights reserved).
- 25 July 2026
- Published by Elsevier in Neuroscience Letters
- Vol. 884, 138691
Silicon-based agent attenuates cerebral ischemia–reperfusion injury in a rat model
- 25 July 2026
- Published by Elsevier in Neuroscience Letters
- Vol. 884, 138691
Silicon-based agent attenuates cerebral ischemia–reperfusion injury in a rat model
- Open Access
- 16 July 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 47, 102715
Vestibular functional assessment using the caloric test in mice with arsanilic acid–induced vestibular dysfunction
- 16 July 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 47, 102715
Open AccessVestibular functional assessment using the caloric test in mice with arsanilic acid–induced vestibular dysfunction
- Open Access
- 8 July 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 47, 102707
Establishment and characterization of a mouse model of cisplatin-induced olfactory aversion
- 8 July 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 47, 102707
Open AccessEstablishment and characterization of a mouse model of cisplatin-induced olfactory aversion
- Open Access
- 10 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16  (1)
Graded surgical stress reveals postoperative behavioral changes associated with systemic oxidative stress
Postoperative delirium (POD) is a postoperative complication characterized by acute-onset attention deficits and cognitive impairment following surgery. Recently, oxidative stress has been increasingly recognized in its pathogenesis. This study investigated the relationship between postoperative behavioral changes and systemic oxidative stress responses under graded levels of surgical stress. Male C57BL/6J mice were divided into three groups: anesthesia alone, standard laparotomy, and open surgery with added localized thermal injury (OPT). The buried food test was performed 24 h after anesthesia induction to evaluate search latency. Serum was collected after the behavioral test to measure derivatives of reactive oxygen metabolites (d-ROMs), biological antioxidant potential (BAP), and the BAP/d-ROMs ratio. Search latency became more prolonged under conditions of increased surgical invasiveness. The d-ROMs values increased progressively with increasing surgical stress, whereas the BAP/d-ROMs ratio progressively decreased. Group-stratified and interaction analyses suggested that the relationship between postoperative behavioral changes and systemic oxidative stress responses differed according to the degree of surgical invasiveness, particularly regarding the BAP/d-ROMs ratio. These findings suggest that oxidative stress responses may contribute differently to postoperative behavioral changes under different levels of graded surgical stress.
- 10 June 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16  (1)
Open AccessGraded surgical stress reveals postoperative behavioral changes associated with systemic oxidative stress
Postoperative delirium (POD) is a postoperative complication characterized by acute-onset attention deficits and cognitive impairment following surgery. Recently, oxidative stress has been increasingly recognized in its pathogenesis. This study investigated the relationship between postoperative behavioral changes and systemic oxidative stress responses under graded levels of surgical stress. Male C57BL/6J mice were divided into three groups: anesthesia alone, standard laparotomy, and open surgery with added localized thermal injury (OPT). The buried food test was performed 24 h after anesthesia induction to evaluate search latency. Serum was collected after the behavioral test to measure derivatives of reactive oxygen metabolites (d-ROMs), biological antioxidant potential (BAP), and the BAP/d-ROMs ratio. Search latency became more prolonged under conditions of increased surgical invasiveness. The d-ROMs values increased progressively with increasing surgical stress, whereas the BAP/d-ROMs ratio progressively decreased. Group-stratified and interaction analyses suggested that the relationship between postoperative behavioral changes and systemic oxidative stress responses differed according to the degree of surgical invasiveness, particularly regarding the BAP/d-ROMs ratio. These findings suggest that oxidative stress responses may contribute differently to postoperative behavioral changes under different levels of graded surgical stress.